China’s 2025 Pharmacopoeia Edition Approved, Set for October 1 Implementation
The Pharmacopoeia of the People’s Republic of China (2025 Edition), released by the National Medical...
Alphamab Oncology Reports 192.58% Revenue Surge Led by Envafolimab
Alphamab Oncology (HKG: 9966) has announced its 2024 financial results, marking a significant milestone with...
Shanghai Henlius Biotech Receives NMPA Approval for HLX79 in Glomerulonephritis Trial
China’s Shanghai Henlius Biotech Inc. (HKG: 2696) has announced receiving approval from the National Medical...
Chia Tai Tianqing’s TQB2210 Approved for Advanced Malignant Tumor Study
The Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has approved...
CanSino Biologics Partners with Saudi SPIMACO to Boost Meningococcal Vaccine Access
China-based CanSino Biologics Inc. (HKG: 6185) has entered into a collaboration agreement with Saudi pharmaceutical...
Everest Medicines Reports Surge in Revenue, Advances Core Products and R&D Pipeline
China-based Everest Medicines (HKG: 1952) has announced its 2024 financial results, marking a significant milestone...
Jiangsu Hengrui Pharmaceuticals Inks Global License Deal with Merck for HRS-5346
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) announced a license agreement with US-based giant Merck...
Sichuan Kelun-Biotech Gains NMPA Approval for SKB107 Bone Metastasis Trial
China-based Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd (HKG: 6990) has announced receiving approval from the National...
Abbisko Therapeutics Receives NMPA Approval for ACH Drug ABSK061
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) has announced receiving clinical trial approval from...
Fapon Biotech Partners with Sansure to Develop Next-Generation Diagnostic Solutions
China-based biotech Fapon Biotech Inc. has formed a strategic partnership with molecular diagnostics specialist Sansure...
AstraZeneca Officially Launches Fasenra for Severe Eosinophilic Asthma in China
UK-based pharmaceutical giant AstraZeneca Inc. (NASDAQ: AZN) has announced the official market launch of its...
United Laboratories Inks Global Licensing Deal with Novo Nordisk for Obesity Drug
Hong Kong-based United Laboratories International Holdings Ltd (HKG: 3933) has entered into a licensing agreement...
Fapon Biotech Partners with Tencent Healthcare to Boost IVD and Medical Device Fields
China-based biotech Fapon Biotech Inc. has formed a strategic partnership with Tencent Healthcare, the healthcare...
Joint Biosciences’ OVV-01 Receives FDA Fast Track Designation for Soft Tissue Sarcoma Trial
Shanghai-based Joint Biosciences Ltd., a developer of tumor combined immunotherapies, has announced receiving fast track...
Sino Biopharmaceutical’s Culmerciclib Shows Positive Results in Phase III Breast Cancer Trial
China-based Sino Biopharmaceutical Ltd (HKG: 1177) has revealed positive results from the Phase III TQB3616-III-02...
Humanwell Healthcare Receives NMPA Approval for Caplyta Generic in Schizophrenia Trial
China-based Humanwell Healthcare (Group) Co., Ltd (SHA: 600079) has announced receiving clinical trial approval from...
Clover Biopharmaceuticals Receives Termination Notice from GAVI for COVID-19 Vaccine Agreement
China-based Clover Biopharmaceuticals Ltd., (HKG: 2197) announced receiving a one-month prior written notice dated March...
Simcere Pharmaceutical Group Reports Steady Revenue Amid R&D Investment Shift
China-based Simcere Pharmaceutical Group (HKG: 2096) has released its 2024 financial performance report, recording RMB...
Henlius Biotech Reports 6.1% Revenue Growth with Strong Oncology Product Sales
Shanghai Henlius Biotech Inc. (HKG: 2696) has published its 2024 financial results, recording revenues of...
Sichuan Kelun-Biotech Reports 25.5% Revenue Growth with Key Drug Approvals
China-based Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd (HKG: 6990) has released its 2024 financial report, recording...